Updated Jul 16, 2026
JEAN CHRISTOPHE has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Christophe Jean is identified in SEC filings as a director of Rhythm Pharmaceuticals, Inc. as of June 25, 2026. The available SEC context confirms his role as a member of the board; additional public biographical details are not provided in the given filings.
| Role | Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-25 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 4.7K | — |
Christophe Jean is identified in SEC filings as a director of Rhythm Pharmaceuticals, Inc. as of June 25, 2026. The available SEC context confirms his role as a member of the board; additional public biographical details are not provided in the given filings.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live JEAN CHRISTOPHE profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.